Medpedia

News & Analysis » Medical Specialties » Onco'Zine - The International Cancer Network

JX-594's Cancer Targeting Mechanism Driven by Genetic Traits Common in Solid Tumors

By Peter Hofland, PhD
Feb 07, 12 04:30AM | 0 comments

A new study published in Molecular Therapy shows that JX-594, a first-in-class targeted oncolytic virus products for cancer being developed by Jennerex, Inc selectively targets and kills a broad range of cancer cells.

The study demonstrated that JX-594's cancer-selectivity was multi-mechanistic and…

Link to original post

Comments

To add a comment to the original post, click here.

You must be signed in to post a comment.

Sign in now

There are no comments for this post.

Contributor

Onco'Zine - The International Cancer Network

More from this contributor

»» See all Posts

Browse News & Analysis by Channel

Browse News & Analysis by Keywords

Health 2.0 Health Policy & Management Healthcare Dementia Medical education Health Care Reform Global Health Alzheimer Disease Research Medical Students Psychiatry Diet Breast Neoplasms Health Obesity Public Health Nutrition Women's Health Information Science Attention Deficit Disorder with Hyperactivity Emergency Medicine Diabetes Mellitus Technology Medicine Pain
» See all
Medpedia Portals - Adult Primary Care Allergy and Immunology Anatomy Cardiology Emergency Medicine Endocrinology Epidemiology Gastroenterology and Hepatology General Medicine Infectious Diseases Internal Medicine Neurology & Neurobiology Nutrition OB/GYN and Reproductive Health Oncology Orthopedics Pathology Pediatrics Pharmacology Psychiatry Public Health Pulmonology Rheumatology Women's Health
Editor Directory - browse by last initial
ABCDEFGHIJKLMNOPQRSTUVWXYZ
Professional Directory - browse by last initial
ABCDEFGHIJKLMNOPQRSTUVWXYZ
About Medpedia | Privacy Policy | Terms of Use | Contact | Press | FAQ | Medical School Network
Content on this page is the sole copyright of the author.
Cancel
Cancel